| ELTX |
Elicio Therapeutics, Inc. |
53.35m |
1.84 |
(2.13%) |
0.00 |
0.00% |
921.02% |
— |
| IMA |
ImageneBio, Inc. |
52.90m |
4.72 |
1.29% |
0.00 |
0.00% |
(67.95%) |
— |
| TVGN |
Tevogen Inc. |
51.12m |
7.25 |
(7.64%) |
0.00 |
0.00% |
— |
— |
| LITS |
Lite Strategy, Inc. |
51.04m |
1.44 |
0.70% |
0.00 |
0.00% |
152.90% |
— |
| DWTX |
Dogwood Therapeutics, Inc |
48.61m |
1.36 |
(4.90%) |
0.00 |
0.00% |
— |
— |
| TIL |
Instil Bio, Inc. |
48.29m |
7.17 |
0.70% |
0.00 |
0.00% |
— |
— |
| IBO |
Impact Biomedical Inc. |
48.27m |
5.69 |
0.71% |
6.45 |
2,254.29% |
— |
— |
| HOWL |
Werewolf Therapeutics, Inc. |
47.68m |
0.96 |
(2.04%) |
0.00 |
(141.94%) |
(5.21%) |
— |
| GRCE |
Grace Therapeutics, Inc. |
45.44m |
2.12 |
(1.85%) |
0.00 |
0.00% |
1,286.81% |
— |
| PDSB |
PDS Biotechnology Corporation |
44.21m |
0.80 |
0.00% |
0.00 |
0.00% |
— |
— |
| MGX |
Metagenomi Therapeutics, Inc. |
43.44m |
1.15 |
0.00% |
0.00 |
(689.20%) |
(59.84%) |
— |
| VERU |
Veru Inc. |
42.80m |
2.54 |
1.20% |
0.00 |
0.00% |
42.13% |
— |
| SGMOQ |
Sangamo Therapeutics, Inc. |
41.89m |
0.14 |
(6.67%) |
0.00 |
(356.89%) |
(45.80%) |
— |
| KPTI |
Karyopharm Therapeutics Inc. |
39.24m |
1.62 |
(6.36%) |
0.00 |
(153.28%) |
6.81% |
— |
| IMMP |
Prima BioMed Ltd |
38.48m |
0.26 |
0.00% |
0.00 |
— |
— |
— |
| CELU |
Celularity, Inc. |
38.21m |
1.38 |
4.55% |
0.00 |
(345.76%) |
(51.03%) |
— |
| CRVO |
CervoMed Inc. |
38.10m |
2.54 |
0.79% |
0.00 |
0.00% |
(58.86%) |
— |
| NNVC |
NanoViricides, Inc. |
38.04m |
1.44 |
0.00% |
0.00 |
0.00% |
— |
— |
| FLNA |
Cassava Sciences, Inc. |
37.79m |
0.75 |
(2.60%) |
0.00 |
0.00% |
277.58% |
— |
| ATNM |
Actinium Pharmaceuticals, Inc. |
37.42m |
1.20 |
0.84% |
3.33 |
32.18% |
2,731.18% |
— |
| BCTX |
BRIACELL THERAP |
37.24m |
4.32 |
0.93% |
1.94 |
0.00% |
— |
— |
| LBPS |
4D pharma PLC Sponsored ADR |
37.19m |
— |
0.00% |
0.00 |
(9,577.06%) |
— |
— |
| MCRB |
Seres Therapeutics, Inc. |
35.99m |
3.52 |
(2.76%) |
0.00 |
(1,192.94%) |
(98.51%) |
— |
| LIANY |
LianBio Sponsored ADR |
34.19m |
0.06 |
0.00% |
0.02 |
0.00% |
— |
— |
| CNTX |
Context Therapeutics Inc. |
34.10m |
0.35 |
(5.41%) |
0.00 |
0.00% |
— |
— |
| ABVC |
ABVC BioPharma, Inc. |
33.96m |
1.13 |
4.59% |
0.00 |
0.00% |
5,035.43% |
— |
| ALGS |
Aligos Therapeutics, Inc. |
32.60m |
5.51 |
(0.72%) |
0.00 |
(241.01%) |
893.01% |
— |
| GNTA |
Genenta Science S.p.A. Unsponsored ADR |
32.38m |
0.69 |
2.99% |
— |
— |
— |
— |
| ATYR |
aTyr Pharma, Inc. |
31.38m |
0.31 |
(11.76%) |
0.00 |
0.00% |
6.78% |
— |
| QNTM |
Quantum Biopharma Ltd. |
30.89m |
3.85 |
(3.75%) |
0.00 |
0.00% |
— |
— |
| QNCX |
Quince Therapeutics, Inc. |
30.51m |
31.00 |
3.33% |
0.00 |
0.00% |
— |
— |
| CVM |
Cel-Sci Corporation |
30.25m |
1.67 |
(2.91%) |
0.00 |
0.00% |
20.75% |
— |
| BYSI |
BeyondSpring Inc. |
29.81m |
0.78 |
6.85% |
0.00 |
0.00% |
— |
— |
| IGC |
IGC Pharma, Inc. |
29.11m |
0.28 |
0.00% |
0.00 |
(795.46%) |
(13.38%) |
— |
| KYNB |
Kyntra Bio Inc |
28.34m |
6.94 |
(0.86%) |
0.15 |
3,967.77% |
(37.15%) |
— |
| RNAZ |
TransCode Therapeutics Inc. |
27.94m |
1.69 |
2.42% |
0.00 |
0.00% |
— |
— |
| EVAX |
Evaxion A/S - Sponsored ADR |
27.19m |
3.34 |
1.53% |
0.00 |
0.00% |
— |
— |
| GRDX |
GridAI Technologies Corp. |
27.17m |
3.43 |
(5.51%) |
0.00 |
0.00% |
— |
— |
| NXTC |
NextCure, Inc. |
25.36m |
5.08 |
(3.79%) |
0.00 |
0.00% |
— |
— |
| PLRZ |
Polyrizon Ltd. |
24.93m |
10.78 |
2.57% |
— |
— |
— |
— |
| RADX |
Radiopharm Theranostics Limited - Sponsored ADR |
24.68m |
1.65 |
5.10% |
— |
— |
— |
— |
| CYAD |
Celyad SA |
23.79m |
— |
1.85% |
0.00 |
0.00% |
— |
— |
| TCRX |
TScan Therapeutics, Inc. |
23.65m |
0.34 |
(2.86%) |
0.00 |
(1,655.35%) |
2.15% |
— |
| PBM |
Psyence Biomedical Ltd. |
22.35m |
5.56 |
(5.12%) |
0.25 |
0.00% |
— |
— |
| COCP |
Cocrystal Pharma, Inc. |
22.15m |
1.17 |
1.74% |
0.00 |
(747.78%) |
(30.38%) |
— |
| ESLA |
Estrella Immunopharma, Inc. |
20.49m |
0.48 |
2.13% |
0.00 |
0.00% |
— |
— |
| ATOS |
Atossa Therapeutics, Inc. |
20.46m |
1.90 |
(7.32%) |
0.00 |
0.00% |
(93.66%) |
— |
| MRKR |
MARKER THERAPEUTICS, INC. |
19.84m |
1.15 |
(3.36%) |
0.00 |
0.00% |
(27.83%) |
— |
| NEUP |
Neuphoria Therapeutics Inc. |
19.75m |
3.65 |
0.00% |
0.00 |
0.00% |
3,535.05% |
— |
| CLRB |
Cellectar Biosciences, Inc. |
19.61m |
1.80 |
(13.46%) |
0.00 |
0.00% |
— |
— |
| JSPR |
Jasper Therapeutics, Inc. |
19.45m |
0.61 |
3.39% |
0.00 |
0.00% |
— |
— |
| AKTX |
Akari Therapeutics PLC |
17.61m |
9.76 |
(2.98%) |
0.00 |
0.00% |
— |
— |
| ANEB |
Anebulo Pharmaceuticals, Inc. |
17.60m |
0.33 |
0.00% |
0.00 |
0.00% |
— |
— |
| PTN |
Palatin Technologies, Inc. |
17.49m |
10.10 |
2.75% |
2.43 |
(47.22%) |
86.46% |
— |
| DYAI |
Dyadic International Inc. |
17.44m |
0.42 |
(4.55%) |
0.00 |
(200.46%) |
(8.05%) |
— |
| ALLR |
Allarity Therapeutics, Inc. |
17.34m |
1.03 |
(5.50%) |
0.00 |
0.00% |
— |
— |
| LPCN |
Lipocine Inc. |
17.23m |
2.10 |
0.48% |
0.00 |
(755.11%) |
(63.48%) |
— |
| KTTA |
Pasithea Therapeutics Corp. |
17.17m |
0.50 |
(1.96%) |
0.00 |
0.00% |
— |
— |
| ACGN |
Aceragen, Inc. |
17.15m |
— |
(15.97%) |
0.00 |
(467.53%) |
1,226.28% |
— |
| BCDA |
BioCardia, Inc. |
16.20m |
1.05 |
(1.87%) |
0.00 |
0.00% |
0.71% |
— |
| CMMB |
Chemomab Therapeutics Ltd. Sponsored ADR |
15.95m |
2.16 |
(1.82%) |
0.00 |
0.00% |
— |
— |
| ACTU |
Actuate Therapeutics, Inc. |
15.85m |
0.68 |
9.68% |
0.00 |
0.00% |
— |
— |
| CTXR |
Citius Pharmaceuticals, Inc. |
15.65m |
0.58 |
1.75% |
0.00 |
0.00% |
— |
— |
| NCEL |
NewcelX Ltd. |
15.56m |
2.95 |
2.08% |
0.00 |
0.00% |
— |
— |
| VAXX |
Vaxxinity, Inc. |
15.47m |
0.00 |
0.00% |
0.00 |
0.00% |
— |
— |
| LTRN |
Lantern Pharma Inc. |
15.47m |
1.22 |
0.83% |
0.00 |
0.00% |
— |
— |
| PASG |
Passage Bio, Inc. |
15.45m |
4.80 |
0.00% |
0.00 |
0.00% |
— |
— |
| ICU |
SeaStar Medical Holding Corporation |
15.16m |
3.42 |
(0.58%) |
0.00 |
(795.50%) |
123.63% |
— |
| TVRD |
Tvardi Therapeutics, Inc. |
14.67m |
1.27 |
19.81% |
0.00 |
0.00% |
(34.36%) |
— |
| ADAPY |
Adaptimmune Therapeutics PLC |
14.55m |
0.03 |
50.00% |
0.00 |
(262.46%) |
(53.99%) |
— |
| DARE |
Dare Bioscience, Inc. |
14.50m |
0.78 |
5.41% |
0.00 |
(804.33%) |
7,817.51% |
— |
| HIND |
Vyome Holdings, Inc. |
14.46m |
2.04 |
(0.97%) |
0.00 |
(8,711.71%) |
103.81% |
— |
| TPST |
Tempest Therapeutics, Inc. |
14.39m |
0.83 |
(2.35%) |
0.00 |
0.00% |
(52.98%) |
— |
| CNSY |
Cerenome, Inc. |
14.26m |
1.99 |
6.42% |
0.00 |
(526.48%) |
(20.95%) |
— |
| CLVSQ |
Clovis Oncology, Inc. |
14.23m |
— |
12.50% |
0.00 |
(189.37%) |
(14.78%) |
— |
| RVLP |
RVL Pharmaceuticals PLC |
14.08m |
— |
0.00% |
0.00 |
(184.91%) |
5.64% |
— |
| NRSN |
NeuroSense Therapeutics Ltd. |
14.04m |
6.95 |
(6.08%) |
0.00 |
0.00% |
— |
— |
| BIVI |
BioVie Inc. |
13.82m |
1.61 |
0.00% |
0.00 |
0.00% |
— |
— |
| LSTA |
Lisata Therapeutics, Inc. |
13.52m |
1.58 |
5.33% |
0.00 |
0.00% |
(24.67%) |
— |
| PLUR |
Pluri Inc. |
12.96m |
1.01 |
0.00% |
0.00 |
(2,344.59%) |
(23.95%) |
— |
| QNRX |
Quoin Pharmaceuticals, Ltd. Sponsored ADR |
12.82m |
6.43 |
0.78% |
0.00 |
0.00% |
— |
— |
| INTS |
Intensity Therapeutics Inc. |
12.70m |
3.80 |
(3.99%) |
0.00 |
0.00% |
— |
— |
| AEON |
AEON Biopharma, Inc. |
12.65m |
0.26 |
0.00% |
0.00 |
0.00% |
— |
— |
| VTGN |
VistaGen Therapeutics, Inc. |
12.65m |
0.27 |
(10.00%) |
0.00 |
(2,703.72%) |
287.15% |
— |
| BLRX |
BioLineRx Ltd. |
12.55m |
2.60 |
1.19% |
0.00 |
(502.08%) |
(91.93%) |
— |
| PHIO |
Phio Pharmaceuticals Corp. |
12.43m |
1.01 |
(0.98%) |
0.00 |
0.00% |
78.95% |
— |
| CASIF |
CASI Pharmaceuticals Inc. |
12.39m |
0.13 |
(18.75%) |
0.00 |
(232.03%) |
(27.42%) |
— |
| GTBP |
GT Biopharma, Inc. |
12.32m |
6.89 |
0.88% |
0.00 |
0.00% |
(76.19%) |
— |
| ASBP |
Aspire Biopharma Holdings, Inc. |
12.20m |
8.32 |
(4.37%) |
0.23 |
(11,309.31%) |
— |
— |
| CALC |
CalciMedica Inc. |
11.88m |
1.75 |
0.57% |
0.00 |
0.00% |
— |
— |
| KPRX |
Kiora Pharmaceuticals, Inc. |
11.81m |
2.63 |
(1.50%) |
0.00 |
0.00% |
983.73% |
— |
| ADIL |
Adial Pharmaceuticals, Inc. |
11.33m |
4.22 |
(4.28%) |
0.00 |
0.00% |
— |
— |
| ENLV |
Enlivex Ltd. |
11.33m |
0.60 |
(1.64%) |
0.00 |
0.00% |
— |
— |
| MBRX |
Moleculin Biotech, Inc. |
11.17m |
0.60 |
5.26% |
0.05 |
0.00% |
— |
— |
| INAB |
IN8bio, Inc. |
11.14m |
1.20 |
0.84% |
0.00 |
0.00% |
— |
— |
| MTVA |
MetaVia Inc. |
10.94m |
1.66 |
1.84% |
0.00 |
0.00% |
— |
— |
| GDTC |
CytoMed Therapeutics Limited |
10.77m |
0.96 |
5.49% |
0.00 |
0.00% |
— |
— |
| KALA |
KALA BIO, Inc. |
10.73m |
0.48 |
(14.29%) |
0.00 |
0.00% |
(50.54%) |
— |
| TOVX |
Theriva Biologics, Inc. |
10.58m |
0.22 |
(4.35%) |
0.16 |
0.00% |
— |
— |
| AZTR |
Azitra, Inc. |
10.10m |
0.17 |
0.00% |
2.54 |
0.00% |
58.18% |
— |